Reviva Pharmaceuticals HoldiRVPH
13F holders, Q4 2025 (December 31)2holders +1
1new positions
0sold out
$0.35avg. 13F price*
At the end of Q4 2025, 2 institutions reported holding Reviva Pharmaceuticals Holdi (RVPH) in their 13F filings, up 1 from Q3 2025. 1 opened new positions and 0 sold out. The largest holders were Sound Income Strategies, LLC ($11K) and Fortitude Family Office, LLC ($687).
- Company
- Reviva Pharmaceuticals Holdi
- CUSIP
- G8708A116
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $687 |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 2,464 shares bought, net +2,464 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Sound Income Strategies, LLC | 0.00% | No change | 30,000 | $11K |
| Fortitude Family Office, LLC | 0.00% | New | 2,464 | $687 |
"% of holder's portfolio" is RVPH's weight in each manager's 13F, not the share of Reviva Pharmaceuticals Holdi the manager owns.